These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28017562)

  • 1. Optimization of non-linear gradient in hydrophobic interaction chromatography for the analytical characterization of antibody-drug conjugates.
    Bobály B; Randazzo GM; Rudaz S; Guillarme D; Fekete S
    J Chromatogr A; 2017 Jan; 1481():82-91. PubMed ID: 28017562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical method development for the separation of monoclonal antibodies and antibody-drug-conjugate species in hydrophobic interaction chromatography, part 1: optimization of the mobile phase.
    Rodriguez-Aller M; Guillarme D; Beck A; Fekete S
    J Pharm Biomed Anal; 2016 Jan; 118():393-403. PubMed ID: 26609679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.
    Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species.
    Sarrut M; Fekete S; Janin-Bussat MC; Colas O; Guillarme D; Beck A; Heinisch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():91-102. PubMed ID: 27426265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography.
    Ouyang J
    Methods Mol Biol; 2013; 1045():275-83. PubMed ID: 23913154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADC Analysis by Hydrophobic Interaction Chromatography.
    Fleming R
    Methods Mol Biol; 2020; 2078():147-161. PubMed ID: 31643055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of antibody drug conjugate species by RPLC: A generic method development approach.
    Fekete S; Molnár I; Guillarme D
    J Pharm Biomed Anal; 2017 Apr; 137():60-69. PubMed ID: 28092856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
    Yan Y; Xing T; Wang S; Daly TJ; Li N
    J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
    Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
    Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
    Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry.
    D'Atri V; Fekete S; Stoll D; Lauber M; Beck A; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():37-41. PubMed ID: 29477065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streamlined Characterization of an Antibody-Drug Conjugate by Two-Dimensional and Four-Dimensional Liquid Chromatography/Mass Spectrometry.
    Goyon A; Kim M; Dai L; Cornell C; Jacobson F; Guillarme D; Stella C
    Anal Chem; 2019 Dec; 91(23):14896-14903. PubMed ID: 31621311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
    Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
    J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of hydrophobic interaction chromatography for the separation of antibody-drug conjugates and its application towards quality by design.
    Andris S; Hubbuch J
    J Biotechnol; 2020 Jun; 317():48-58. PubMed ID: 32361022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native size-exclusion chromatography-mass spectrometry: suitability for antibody-drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels.
    Jones J; Pack L; Hunter JH; Valliere-Douglass JF
    MAbs; 2020; 12(1):1682895. PubMed ID: 31769727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of ADCs by Hydrophobic Interaction Chromatography.
    Becker CL; Duffy RJ; Gandarilla J; Richter SM
    Methods Mol Biol; 2020; 2078():273-290. PubMed ID: 31643064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput oxidation screen of antibody-drug conjugates by analytical protein A chromatography following IdeS digest.
    Buecheler JW; Winzer M; Weber C; Gieseler H
    J Pharm Pharmacol; 2018 May; 70(5):625-635. PubMed ID: 29380379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates?
    D'Atri V; Pell R; Clarke A; Guillarme D; Fekete S
    J Chromatogr A; 2019 Feb; 1586():149-153. PubMed ID: 30554777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
    Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
    MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.